GC Green Cross Medical Foundation Unveils 'Epi-wave' Real-Time Infectious Disease Surveillance Dashboard

Weekly Analysis of 17 Infectious Disease Outbreaks Provided

GC Green Cross Medical Foundation announced on May 15 that it has released the infectious disease data visualization dashboard, 'Epi-wave,' on its official website, enabling real-time monitoring and prediction of infectious disease outbreaks.

Status data of influenza positive rate in 'Epi-wave.' GC Green Cross Medical Foundation

'Epi-wave' is built on the foundation's testing data from the past three years and provides weekly analyses of a total of 17 infectious diseases, including 12 types of respiratory infections and 5 types of influenza and gastrointestinal infections.

The dashboard's main feature is its user-oriented visualizations. Data from 2024 up to the present in 2026 is presented in bar graphs and epidemic curves, allowing users to easily compare annual outbreak trends at a glance. Notably, when a specific infectious disease is selected, users can view positive rates by gender and age, as well as detailed outbreak status by region through an interactive map, supporting tailored regional responses.

More specifically, ▲the respiratory infection dashboard analyzes 10 types of viruses, such as adenovirus and rhinovirus, as well as 2 types of bacteria, including Mycoplasma pneumoniae; ▲the gastrointestinal infection dashboard covers 5 types, such as norovirus and rotavirus; and ▲the influenza dashboard provides a professional analysis environment by presenting subtype- and age-specific epidemic curves alongside regional positive rate maps on a single screen.

This dashboard was developed with support from the 'Pan-Ministerial Infectious Disease Response System Advancement R&D Project' and is expected to play a key role in improving clinical efficiency in medical settings and strengthening local communities' capacity to respond to infectious diseases.

Lee Sangkon, President of GC Green Cross Medical Foundation, stated, "Epi-wave is the result of combining our foundation's high-quality testing data with digital health technology to create public value," and added, "We will continue to advance our infectious disease surveillance capabilities to further reinforce the national disease control system."

This content was produced with the assistance of AI translation services.